Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Two River is a venture capital firm based in North America, specializing in the life sciences sector. The firm partners with scientific founders and experienced management teams to build companies that focus on oncology, immunotherapy, and synthetic biology. They manage a portfolio of nine companies, leveraging their capital and expertise to support innovative research.
Two River invests in seed to Series B stage companies within the life sciences sector, specifically targeting groundbreaking science that can significantly improve patient outcomes. They provide not only capital but also operational capabilities, corporate development, transaction support, and leadership recruitment to assist scientific founders in advancing their research.
Notable portfolio companies include Allogene Therapeutics, developing CAR T therapy for blood cancers; Kite Pharma, known for its FDA-approved CAR T therapy Yescarta™; and Neogene Therapeutics, specializing in next-generation T-cell receptor therapies. Other companies include Breakthrough Properties, Candid Therapeutics, Cell Design Labs, Kronos Bio, Symbiotic Capital, and Vida Ventures.
Two River invests in seed, Series A, and Series B stages, focusing on early to growth-stage life science companies.
The firm specializes in the life sciences sector, with a particular emphasis on oncology, immunotherapy, and synthetic biology.
Two River provides capital, operational capabilities, corporate development, transaction support, and leadership recruitment to help scientific founders advance their research.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.